Vaccine-preventable disease - 840539006
View vaccine-preventable disease subset
Concept details
COVID-19
Pan-Canadian SNOMED CT terminology
- Concept code
- 840539006
- Concept status
- active
- Version
- 20210331
- Display name
- English: COVID-19
- French: COVID-19
- Fully specified name
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)
Linked concepts
Linked generic concept(s)
Linked tradename concept(s)
- [COVID-19] Abdala
- [COVID-19] COMIRNATY (original strain) 30 mcg/0.3 mL
- [COVID-19] COMIRNATY (original strain) pediatric 10 mcg/0.2 mL
- [COVID-19] COMIRNATY (original strain) pediatric 3 mcg/0.2 mL
- [COVID-19] COMIRNATY (original strain) tris-sucrose 30 mcg/0.3 mL
- [COVID-19] COMIRNATY 30 mcg/0.3 mL
- [COVID-19] COMIRNATY Omicron XBB.1.5 30 mcg/0.3 mL
- [COVID-19] COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.2 mL
- [COVID-19] COMIRNATY Omicron XBB.1.5 pediatric 10 mcg/0.3 mL
- [COVID-19] COMIRNATY Omicron XBB.1.5 pediatric 3 mcg/0.2 mL
- [COVID-19] COMIRNATY Original & Omicron BA.4/BA.5 30 mcg/0.3 mL
- [COVID-19] COMIRNATY Original & Omicron BA.4/BA.5 pediatric 10 mcg/0.2mL
- [COVID-19] COMIRNATY Original & Omicron BA.4/BA.5 pediatric 3 mcg/0.2mL
- [COVID-19] COMIRNATY Original / Omicron BA.1 30 mcg/0.3 mL
- [COVID-19] COMIRNATY pediatric 10 mcg/0.2 mL
- [COVID-19] COMIRNATY pediatric 10 mcg/0.3 mL
- [COVID-19] COMIRNATY pediatric 3 mcg/0.2 mL
- [COVID-19] COMIRNATY pediatric 3 mcg/0.3 mL
- [COVID-19] Convidecia
- [COVID-19] CORBEVAX
- [COVID-19] CoronaVac
- [COVID-19] COVAXIN
- [COVID-19] COVIFENZ
- [COVID-19] COVIran Barekat
- [COVID-19] COVISHIELD
- [COVID-19] CoviVac
- [COVID-19] COVOVAX
- [COVID-19] CureVac
- [COVID-19] EpiVacCorona
- [COVID-19] JCOVDEN
- [COVID-19] KCONVAC
- [COVID-19] Medgen-Dynavax-NIAID
- [COVID-19] NUVAXOVID
- [COVID-19] NUVAXOVID (original strain)
- [COVID-19] NUVAXOVID Omicron XBB.1.5
- [COVID-19] QazCovid-in
- [COVID-19] SINOPHARM-BIBP
- [COVID-19] SINOPHARM-WIBP
- [COVID-19] Soberana 02
- [COVID-19] SPIKEVAX (original strain) 0.10 mg/mL
- [COVID-19] SPIKEVAX (original strain) 0.20 mg/mL
- [COVID-19] SPIKEVAX 0.10 mg/mL
- [COVID-19] SPIKEVAX Bivalent (Original / Omicron BA.1) 0.10 mg/mL
- [COVID-19] SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL
- [COVID-19] SPIKEVAX XBB.1.5 0.10 mg/mL
- [COVID-19] SpikoGen
- [COVID-19] Sputnik Light
- [COVID-19] Sputnik V
- [COVID-19] VAXZEVRIA
- [COVID-19] VidPrevtyn Beta
- [COVID-19] ZIFIVAX
- [COVID-19]SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 10 mcg/0.2 mL
Linked antigen/immunoglobulin/antitoxin concept(s)
National Vaccine Catalogue database details
- Last updated
- 2024-03-24
Concept history
This concept replaces
Concept code | Display name |
---|---|
No data is available |
Notice
Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.
Disclaimer
The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.
- Version:
- 1.0.12